Skip to content Skip to navigation

Remote monitoring patch wins FDA clearance

September 3, 2014
by Richard R. Rogoski
| Reprints

San Jose, Calif.-based Vital Connect has announced that its HealthPatch MD wearable monitoring patch has been cleared by the U.S. Food and Drug Administration (FDA) for monitoring patients at home.

Weighing only 10 grams with a thickness of 6 mm, the patch allows healthcare providers to remotely monitor vital signs, such as heart rate, heart rate variability, respiratory rate, skin temperature and posture—including fall detection.

Data collected from the sensors are sent to a relay or smartphone via Bluetooth and are stored in a Health Insurance Portability and Accountability Act-compliant cloud. 

The patch was designed primarily for short-term monitoring of those with chronic conditions who were recently discharged from a hospital or who may benefit from around-the-clock monitoring.

“Receiving FDA clearance for HealthPatch MD to be used in home care settings is an important milestone for the future of the healthcare industry,” says Vital Connect CEO Nersi Nazari. “Medical professionals will soon be able to provide unparalleled service to their home care patients because the HealthPatch MD will allow them to know if a patient’s heart rate or respiratory rate, for example, crosses a predetermined threshold and react accordingly."